In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles is a research paper published in Journal of Controlled Release (2021). On theSindex it has a DataRank of 0. It has been cited 99 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1-UG3-NS-111688-01
National Institutes of Health
Grant: 1R24 EY032434
National Institutes of Health
Grant: R01EY024995
National Institutes of Health
Grant: R01HL129785
National Institutes of Health
Grant: R01HL143469
NINDS NIH HHS
Grant: UG3 NS111688
NEI NIH HHS
Grant: R24 EY032434
National Institutes of Health
Grant: 5UG3NS111688-03
Enabling Nanoplatforms for Targeted in vivo Delivery of CRISPR/Cas9 Ribonucleoproteins in the Brain
National Institutes of Health
Grant: 5R01HL143469-03
Targeting PERK: An Endothelium-Protective Stent-Free Strategy for Mitigation of Intimal Hyperplasia After Vascular Surgery
National Institutes of Health
Grant: 5R01EY024995-03
Molecular Therapies for Lebers Congenital Amaurosis Caused by KCNJ13 Mutations
National Institute for Health Research (NIHR)
FWCI
4.45
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords